Rising prevalence of cancer and genetic disorders and increasing government investments in cancer research are some of the key factors expected to drive the market revenue
According to Emergen Research, the global in-situ hybridization market size was USD 905.3 million in 2020 and is expected to reach USD 1,556.6 million in 2028 and register a revenue CAGR of 7.1% during the forecast period, 2021-2028.
Market Dynamics:
The global in-situ hybridization market revenue growth is mainly attributed to increasing geriatric population, rising prevalence of chronic diseases such as cancer and various genetic and infectious diseases across the globe, and surging need for more advanced and effective treatment options for early detection of infected tissue and cells. Increasing focus of pharmaceutical and biotechnological companies in research & development activities for novel and more advanced diagnostics and therapeutics for cancer and other infectious diseases, and rising adoption of in-situ hybridization technology in diagnostic centers are some of the other key factors expected to contribute to the global in-situ hybridization market revenue growth. However, some unfavorable factors such as high costs associated with in-situ hybridization-based treatments is expected to restrain market growth to a certain extent over the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/584
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Kits & Reagents Product Type Segment to Account for Largest Revenue Share:
The kits & reagents segment is expected to dominate other product type segments in terms of largest revenue share in the global market over the forecast period. Increasing cases of cancer and various infectious disorders globally, growing need for technologically advanced kits & reagents for hybridization, pre-hybridization, and post-hybridization treatments are key factors expected to drive revenue growth of this segment.
Fluorescence In-Situ Hybridization Segment Revenue to Expand at a Rapid CAGR:
Based on technology, the fluorescence in-situ hybridization (FISH) segment is expected to register fastest revenue growth rate in the global in-situ hybridization market over the forecast period. Factors contributing to the growth of this segment are increasing applications of the fluorescence in-situ hybridization technology in areas such as defected chromosome identification, drug tracking, and diagnosis of unusual genetic conditions.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America in-situ hybridization market accounted for the largest revenue share in 2020 and is expected register significant revenue growth over the forecast period. Rising prevalence of cancer and various infectious disorders, increasing government investments in pharmaceutical and biotechnological research & development activities, and expected to drive revenue growth of the North America. Presence of state-of-the-art healthcare infrastructure and leading industry players such as Thermo Fisher Scientific, Abbott Laboratories, and Agilent Technologies are some other key factors further boost the revenue growth of the market in the region.
Check Our Prices@ https://www.emergenresearch.com/select-license/584
Major Companies in the Market Include:
- Thermo Fisher Scientific
- Biocare Medical
- Agilent Technologies
- Abbott Laboratories
- Abnova Corporation
- Hoffmann-La Roche Ltd.
- Merck KGAa
- Danaher Corporation
- Bio SB
- BioGenex Laboratories
For the purpose of this report, Emergen Research has segmented the global in-situ hybridization market on the basis of product type, technology, application, end-use, and region:
Product Type Outlook (Revenue, USD Million; 2018–2028)
- Kits & Reagents
- Probes
- Instruments
- Software
- Others
Technology Outlook (Revenue, USD Million; 2018–2028)
- Fluorescence In-Situ Hybridization (FISH)
- Chromogenic In-Situ Hybridization (CISH)
Application Outlook (Revenue, USD Million; 2018–2028)
- Cancer Diagnostics
- Infectious Disease
- Immunology
- Neuroscience
- Cytology
- Others
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals
- Diagnostics Laboratories
- Pharmaceutical and Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Others
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/in-situ-hybridization-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Take a Look at our Related Reports:
Wearable Injectors Market By Technology (Motor-driven. Spring-based), By Type (Off-body, On-body), By Application (Cardiovascular Disease, Diabetes, Immuno-oncology), By End-use (Hospitals, Home Care Settings), and By Region, Forecast to 2028
Oncolytic Virus Therapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Cancer Vaccines, Immunomodulators), By Application (Melanoma, Lung Cancer, Breast Cancer), By End-Use (Hospitals, Clinics, Research Institutes), and By Region, Forecast to 2028
Electrotherapy Market By Treatment Type (Transcutaneous Spinal Electro analgesia (TSE), Interferential Current Therapy (IC), Pulsed Short Wave Diathermy (PSWD), Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Electro-Acupuncture (EA), Percutaneous Electrical Nerve Stimulation (PENS), Others), By Application (Sports Injury, Neuromuscular Dysfunction, Tissue Repair, Urine and Fecal Incontinence, Iontophoresis, Pain Management, Acute and Chronic Edema), By End-Use (Rehabilitation Centers, Long-term Care Centers, Clinics Hospitals, Others), By Region
Tumor Genomics Market By Technique Next Generation Sequencing Technique (NGS), Polymerase Chain Reaction (PCR), Microarray, In-Situ Hybridization (ISH), Immunohistochemistry (ICH), Others (Mass Spectrometry and Flow Cytometry), By Application: Diagnostics and Monitoring, Drug Discovery and Development, Biomarker Discovery, By End use: Academics and Research Organizations, Hospitals and Ambulatory Clinics, Clinical and Diagnostic Laboratories, Biotechnology and Pharmaceutical Companies, By Region, Forecast to 2028
Next Generation Implants (NGI) Market By Application (Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants, Others), By Material (Metals and Metal Alloys, Ceramics, Polymers, Biologics, Others), By End-Use (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Academic and Research Institutes), By Region
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-in-situ-hybridization-market